CY1113348T1 - Χρησιμοποιηση ενωσεων c-(2-φαινυλο-κυκλοεξυλο)-μεθυλαμινης για τη θεραπεια φοβικων διαταραχων - Google Patents

Χρησιμοποιηση ενωσεων c-(2-φαινυλο-κυκλοεξυλο)-μεθυλαμινης για τη θεραπεια φοβικων διαταραχων

Info

Publication number
CY1113348T1
CY1113348T1 CY20111100588T CY111100588T CY1113348T1 CY 1113348 T1 CY1113348 T1 CY 1113348T1 CY 20111100588 T CY20111100588 T CY 20111100588T CY 111100588 T CY111100588 T CY 111100588T CY 1113348 T1 CY1113348 T1 CY 1113348T1
Authority
CY
Cyprus
Prior art keywords
cyclohexyl
dimethylaminomethyl
phenol
methoxyphenyl
methylamine
Prior art date
Application number
CY20111100588T
Other languages
English (en)
Inventor
Petra Bloms-Funke
Werner Englberger
Hagen-Heinrich Hennies
Original Assignee
Grünenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grünenthal GmbH filed Critical Grünenthal GmbH
Publication of CY1113348T1 publication Critical patent/CY1113348T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η παρούσα εφεύρεση αφορά τη χρησιμοποίηση [2-(3-μεθοξυφαινυλο)-κυκλοεξυλομεθυλο]-διμεθυλαμίνης και των μεταβολιτών της για την παρασκευή ενός φαρμάκου για τη θεραπεία καταστάσεων φόβου ή για την παρασκευή ενός ενισχυτικού μέσου για τυποποιημένα αντικαταθλιπτικά και μεθόδους για τη θεραπεία καταστάσεων φόβου ή καταθλίψεων.
CY20111100588T 2003-11-28 2011-06-21 Χρησιμοποιηση ενωσεων c-(2-φαινυλο-κυκλοεξυλο)-μεθυλαμινης για τη θεραπεια φοβικων διαταραχων CY1113348T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10356362A DE10356362A1 (de) 2003-11-28 2003-11-28 Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen
EP04819227A EP1686984B1 (de) 2003-11-28 2004-11-26 Verwendung von c-(2-phenyl-cyclohexyl)-methylaminverbindungen zur therapie von angststörungen

Publications (1)

Publication Number Publication Date
CY1113348T1 true CY1113348T1 (el) 2016-06-22

Family

ID=34609453

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20111100588T CY1113348T1 (el) 2003-11-28 2011-06-21 Χρησιμοποιηση ενωσεων c-(2-φαινυλο-κυκλοεξυλο)-μεθυλαμινης για τη θεραπεια φοβικων διαταραχων
CY20121100904T CY1113162T1 (el) 2003-11-28 2012-09-28 Χρησιμοποιηση ενωσεων c-(2-φαινυλο-κυκλοεξυλο)-μεθυλαμινης για τη θεραπεια φοβικων διαταραχων

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20121100904T CY1113162T1 (el) 2003-11-28 2012-09-28 Χρησιμοποιηση ενωσεων c-(2-φαινυλο-κυκλοεξυλο)-μεθυλαμινης για τη θεραπεια φοβικων διαταραχων

Country Status (14)

Country Link
US (3) US20060258741A1 (el)
EP (2) EP1970060B9 (el)
JP (1) JP5013875B2 (el)
AT (1) ATE509626T1 (el)
CA (1) CA2546672C (el)
CY (2) CY1113348T1 (el)
DE (1) DE10356362A1 (el)
DK (2) DK1970060T3 (el)
ES (2) ES2362752T3 (el)
HR (1) HRP20110608T1 (el)
PL (2) PL1970060T3 (el)
PT (2) PT1686984E (el)
SI (2) SI1970060T1 (el)
WO (1) WO2005051375A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182131A1 (en) * 2002-07-19 2005-08-18 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence
DE102005034973A1 (de) * 2005-07-22 2007-02-15 Grünenthal GmbH Salz von Dimethylaminomethyl-phenyl-cyclohexan und dessen kristalline Formen
DE102005034974A1 (de) * 2005-07-22 2007-04-19 Grünenthal GmbH Salz von Dimethylaminomethyl-phenyl-cyclohexan und dessen kristalline Formen
DE102005061428A1 (de) * 2005-12-22 2007-08-16 Grünenthal GmbH Substituierte Cyclohexylmethyl-Derivate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525137C2 (de) 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
US6387956B1 (en) * 1999-03-24 2002-05-14 University Of Cincinnati Methods of treating obsessive-compulsive spectrum disorders
DE10059411A1 (de) * 2000-11-30 2002-06-13 Gruenenthal Gmbh Verwendung von 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz
DE10109763A1 (de) * 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmazeutische Salze
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
WO2003048113A1 (en) * 2001-11-30 2003-06-12 Sepracor Inc. Tramadol analogs and uses thereof
DE10233048A1 (de) * 2002-07-19 2004-01-29 Grünenthal GmbH Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken
DE10254785A1 (de) * 2002-11-22 2004-06-03 Grünenthal GmbH Kombination ausgewählter Analgetika mit COX II-Inhibitoren
AU2003283410A1 (en) * 2002-11-22 2004-06-18 Grunenthal Gmbh Combination of selected analgesics and cox-ii inhibitors
DE102005011517A1 (de) * 2005-03-10 2006-09-21 Grünenthal GmbH Transdermales therapeutisches System zur Verabreichung von Analgetika
US20090104266A1 (en) * 2005-09-15 2009-04-23 Tobias Jung 3-(2-dimethylaminomethylcy clohexyl)phenol retard formulation

Also Published As

Publication number Publication date
PT1686984E (pt) 2011-05-30
PT1970060E (pt) 2012-10-02
DE10356362A1 (de) 2005-06-23
JP5013875B2 (ja) 2012-08-29
PL1970060T3 (pl) 2012-11-30
SI1686984T1 (sl) 2011-07-29
CY1113162T1 (el) 2016-04-13
CA2546672C (en) 2013-01-22
HRP20110608T1 (hr) 2011-10-31
JP2007512288A (ja) 2007-05-17
ES2362752T3 (es) 2011-07-12
WO2005051375A1 (de) 2005-06-09
PL1686984T3 (pl) 2011-10-31
CA2546672A1 (en) 2005-06-09
EP1970060B9 (de) 2013-01-09
EP1970060A2 (de) 2008-09-17
ES2390931T3 (es) 2012-11-19
EP1686984A1 (de) 2006-08-09
DK1686984T3 (da) 2011-06-20
US20100249225A1 (en) 2010-09-30
EP1970060B1 (de) 2012-08-29
EP1970060A3 (de) 2009-04-15
US20100004341A1 (en) 2010-01-07
ATE509626T1 (de) 2011-06-15
EP1686984B1 (de) 2011-05-18
US20060258741A1 (en) 2006-11-16
SI1970060T1 (sl) 2012-10-30
US8084497B2 (en) 2011-12-27
DK1970060T3 (da) 2012-10-01

Similar Documents

Publication Publication Date Title
US20110160223A1 (en) NMDA Receptor Antagonists for the Treatment of Neuropsychiatric Disorders
JP4185154B2 (ja) 中枢神経系障害治療用の置換モルホリン化合物
CY1113162T1 (el) Χρησιμοποιηση ενωσεων c-(2-φαινυλο-κυκλοεξυλο)-μεθυλαμινης για τη θεραπεια φοβικων διαταραχων
PL2010531T3 (pl) Spirocykliczne pochodne cykloheksanu o działaniu przeciwbólowym
JP2007523955A (ja) 疾患の治療のためのアミンおよびアミド
US20120101105A1 (en) Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
RU2356893C2 (ru) Ингибиторы фосфодиэстеразы 4
AU4195796A (en) Calcium receptor-active compounds
RU2007139543A (ru) Производные бензодиоксана и бензодиоксолана и их применение
RU2012142180A (ru) Ингибиторы катехол-о-метилтрансферазы и их применение для лечения психотических расстройств
JP2012144545A (ja) アルファ−２−デルタリガンドとセロトニン／ノルアドレナリン再取込み阻害薬を含む組合せ
NZ585085A (en) Method of treating arthritis using arylsulfonamide compounds
WO2008087512A1 (en) Morpholine dopamine agonists for the treatment of pain
RU2006107534A (ru) Комбинация, включающая альфа-2-дельта-лиганд анд и ssri и/или snri, для лечения депрессии и тревожного расстройства
JP2006522030A5 (el)
JP6605447B2 (ja) ジスキネジアおよび関連障害を治療する方法
JP2003523993A5 (el)
US20090312367A1 (en) Combination of modafinil and an antagonist or inverse agonist of the h3 receptor
Andrews et al. The Discovery of UK-390957: the Challenge of Targeting a Short Half-life, Rapid Tmax SSRI
US20190225573A1 (en) Vinylogous phenethylamines as neurotransmitter releasers
JPH06293751A (ja) 光学活性ベンゾジオキサン誘導体並びにその化合物を含有する抗鬱剤及び抗不安剤
TH71473A (th) การรวมกันของเฟนิลคาร์บอกซาไมด์ร่วมกับสารปิดกั้นของช่องท่อ IKr และการใช้ของพวกมันสำหรับรักษาภาวะหัวใจห้องบนเสียจังหวะ